Trial intelligence / Profile preview

INNOV CKD 1: Biomarkers in CKD with ACS

NCT06026436Recruiting

Sponsor
Assistance Publique-Hôpitaux de Marseille
Start
Oct 2023
Primary completion
Oct 2026
Countries
1
01

Overview

Open-label, single-arm trial, sponsored by Assistance Publique-Hôpitaux de Marseille. Primary endpoint: Predictive value of high aRap1b expression at 12 months. Started Oct 2023; status: recruiting.

Beyond the preview

Go deeper on NCT06026436.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06026436.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call